1117 Cellular mechanism of a synthetic star polymer platform for systemic STING agonist cancer immunotherapy

• David Wilson,
• Andrew Ishizuka,
• Geoffrey Lynn,
• Qiuyin Ren,
• Yaling Zhu,
• Hojin Yoon,
• Sloane Fussell,
• Robert Seder

Affiliations

David Wilson

Burnet Institute, Melbourne, Victoria, Australia

Andrew Ishizuka

2Avidea Technologies, Washington, USA

Geoffrey Lynn

2Avidea Technologies, Washington, USA

Qiuyin Ren

1Northwestern University, Chicago, IL, USA

Yaling Zhu

3Avidea Technologies, Baltimore, MD, USA

Hojin Yoon

4Vaccitech, Baltimore, MD, USA

Sloane Fussell

2NIH/NIAID/VRC, Bethesda, MD, USA

Robert Seder

2NIH/NIAID/VRC, Bethesda, MD, USA